Sign in
Taking peoplePhase 4

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

Key facts

Who runs it
Hospital de Clinicas de Porto Alegre
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
600 people, planned
Started
Feb 2002
Expected to end
Dec 2032
Type of study
Interventional
Treatments tested
  • Immediate-release Methylphenidate
Record updated
1 November 2016

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • White Brazilian of European descent
  • Fulfillment of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, (DSM-IV) diagnostic criteria for ADHD
  • Eligibility to immediate-release MPH (IR-MPH) treatment

Who cannot take part

  • Evidence of a clinically significant neurological disease that might affect cognition (e.g., delirium, dementia, epilepsy, head trauma, and multiple sclerosis)
  • Current or past history of psychosis
  • Contraindication for IR-MPH use
  • Current stimulant treatment
  • Estimated intelligence quotient score lower than 70

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Methylphenidate (MPH) is the first-line pharmacological treatment for adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Nevertheless, there is considerable interindividual variability regarding the dose required, tolerability and response rates to MPH. The aim of this study is to address the clinical and genetic predictors of MPH treatment outcomes in ADHD.

The group in the trial

  • IR-MPHTreatment being tested

    Immediate-release methylphenidate (IR-MPH) 10 mg two or three times daily with doses increasing weekly until symptom control

    Treatment: Immediate-release Methylphenidate

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
1 November 2016